Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Scynexis said its SCY-770 Phase II trial for ADPKD is due to start by year-end, with an interim efficacy readout expected next year. The company also named Sanjay Subramanian as CFO effective Sept 9, 2026, as Ivor Macleod retires.
SCYNEXIS appointed Sanjay Subramanian as chief financial officer effective September 9, 2026. Ivor Macleod retired from the CFO role effective the same date and will remain through October 9, 2026 to support the transition.